Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia
Stopped Based on our latest research results, we will revise the protocol and design a better study. Since no participants are enrolled till now, we withdraw this study.
Conditions
- Atypical Endometrial Hyperplasia
- Obese
- Fertility Issues
Interventions
- DRUG: Liraglutide Injection
- DRUG: Megestrol Acetate 160 MG
Sponsor
Xiaojun Chen
Collaborators